"[The] executive order to lower drug prices is largely an exercise in applying leverage, rather than actual policymaking -- and it may not amount to much ... The timeline for the administration to actually secure lower drug prices is slippery.... The order is almost certain to be challenged in court, just like a similar most favored nation policy for Medicare was during Trump's first term."  MORE >>